Synta proposes follow-on

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) proposed late Thursday to sell 4 million shares in a follow-on underwritten by Lazard and RBC Capital Markets. If sold at Synta's Thursday close of $5.46, the company would raise $21.8 million. Synta was down $0.01 on the day. ...